Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | 30.56% | $ 43.13M | $ 141.1M |
3/31/2025 | 24.37% | $ 35.96M | $ 147.56M |
12/31/2024 | 18.1% | $ 25M | $ 138.1M |
9/30/2024 | 5.3% | $ 6.71M | $ 126.62M |
6/30/2024 | 4.79% | $ 5.72M | $ 119.57M |
3/31/2024 | 9.08% | $ 10.83M | $ 119.18M |
12/31/2023 | -6.41% | $ -6.48M | $ 101.21M |
9/30/2023 | -45.75% | $ -34.56M | $ 75.55M |
6/30/2023 | -93.26% | $ -61.63M | $ 66.08M |
3/31/2023 | -139.47% | $ -83.02M | $ 59.52M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for CYTOMX THERAPEUTICS INC is calculated as follows: Op. Inc. [ $ -71.2M ] / Revenues [ $ 92.27M ]
(=) Operating % [ -77.17% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |